AVAV Stock Jumps As Laser Weapons And Backlog Surge

AeroVironment Inc. stocks have been trading up by 7.03 percent amid bullish sentiment on expanding defense and drone demand.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading AVAV

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways For AVAV Traders

Won a landmark $464.8M U.S. Army LOCUST X3 laser weapon contract under the E-HEL counter-UAS program, the first large-scale U.S. directed-energy production award spanning multiple years.
Secured a first international direct commercial sale topping $50M for the LOCUST high-energy laser counter-drone system, confirming early global traction for AeroVironment’s directed-energy tech.
Reported record Q1 FY27 revenue of $480.5M with EPS of $0.59 well above expectations, a 1.4x book-to-bill on $0.7B of bookings, and record funded backlog of $1.5B, up 37% year over year.
Delivered sharply improved profitability despite a modest $5.1M GAAP loss as margins expanded and non-GAAP EPS rose from $0.32 to $0.59, signaling better operating leverage for AVAV.
Reaffirmed FY27 revenue guidance of $2.125B–$2.225B and EPS of $3.02–$3.34, and AVAV shares climbed about 4% after earnings, reflecting strong confidence in the multiyear outlook.

Live Update At 15:03:01 EDT: On Thursday, September 10, 2026 AeroVironment Inc. stock [NASDAQ: AVAV] is trending up by 7.03%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

AVAV traders are watching a name that just backed up big headlines with solid numbers. AeroVironment posted record Q1 FY27 revenue of $480.5M, up 6% year over year and above street expectations. More important for swing and position traders, bookings hit $700M, giving AVAV a 1.4x book-to-bill and pushing funded backlog to a record $1.5B, up 37% in a year. That backlog acts like a loaded pipeline of future revenue.

On the bottom line, AVAV printed non-GAAP EPS of $0.59 versus roughly $0.22–$0.25 expected, a sizable earnings beat. GAAP still shows a small $5.1M loss, but that loss narrowed dramatically from $67.4M, and gross margin widened from 21% to 26%. That tells traders the core business is becoming more profitable even as accounting noise from past deals fades.

Guidance matters here. AeroVironment kept its FY27 revenue outlook at $2.125B–$2.225B and EPS at $3.02–$3.34, roughly matching consensus. The market liked it: AVAV stock jumped about 4% after the print, signaling relief that numbers are not rolling over.

On the chart, AVAV has pulled back from the $190s in mid‑August 2026 to the $150 area on 2026/09/10. That’s a meaningful reset, but not a collapse. Over the last few sessions, price has churned between roughly $140 and $160, with 2026/09/10 closing at $150.70 after an intraday high of $159.24. That kind of wide intraday range tells day traders there is plenty of volatility to trade around.

Intraday, the 5‑minute tape on 2026/09/10 shows AVAV opening around $147.50, flushing to $142.50, then squeezing to $159+ before settling near $151. This is classic post‑news action: weak hands shaken out early, momentum buyers chasing the breakout, and then a fade toward the close. For short‑term traders, that creates clear intraday support and resistance levels to lean on.

More Breaking News

Fundamentally, AVAV still carries negative trailing profitability ratios and a price-to-sales around 3.8, but the balance sheet is strong. Debt-to-equity sits near 0.19 with a current ratio above 4.3, giving AeroVironment room to fund growth. For chart‑driven traders, that financial cushion reduces blow‑up risk when sentiment turns.

Why Traders Are Watching AVAV Now

The core of the AVAV story right now is the LOCUST laser weapon franchise. AeroVironment landed a $464.8M U.S. Army production contract under the Enduring‑High Energy Laser (E‑HEL) program to deliver dozens of LOCUST X3 laser weapon systems over the next several years. This is not just another drone order; it is the first large‑scale U.S. directed‑energy weapons production award.

For traders, that matters because it shifts AVAV from “cool prototype shop” into a prime contractor with multi‑year, program‑of‑record revenue. Markets tend to re‑rate names when they cross that line. The $464.8M award, tied to counter‑UAS missions, gives AeroVironment a strong foothold as militaries scramble to deal with hostile drones.

The story is not only domestic. AVAV also secured its first international direct commercial sale for LOCUST worth more than $50M. That one order will not move the entire P&L, but it proves foreign buyers are ready to pay for the same directed‑energy tech the U.S. Army just validated. AeroVironment is responding by investing over $30M to expand manufacturing capacity, a clear signal management expects this stream to last.

Layer on the macro tailwind. New U.S. tariffs of up to 100% on heavier and thermal‑imaging drones and 25% on smaller drones are aimed squarely at Chinese manufacturers. That pushes government and commercial buyers toward domestic suppliers like AVAV. The impact will not be instant, but for longer‑term swing traders it tilts the field in AeroVironment’s favor.

Finally, the NASA/JPL SkyFall mission gives AVAV an extra edge. MacCready Works will co‑design and build three Mars helicopters for a fully funded mission targeting a 2028 launch. The revenue is modest, yet the branding value is huge. Traders know Wall Street pays up for defense names that also sit on cutting‑edge space and autonomy programs.

Conclusion

AVAV is entering a new phase. The combination of a $464.8M U.S. Army LOCUST X3 contract, a >$50M international laser‑weapon order, and record Q1 FY27 results with a $1.5B backlog has turned AeroVironment into a central player in counter‑drone and directed‑energy systems. The stock’s recent pullback from the $190s to around $150, even after a 4% post‑earnings pop, leaves plenty of room for traders to map key levels and potential breakouts.

At the same time, AVAV still reports negative trailing margins, and cash flow is being reinvested, including more than $30M to ramp laser manufacturing. That mix—strong topline growth, improving profitability, and heavy reinvestment—creates volatility. For active traders in the Sykes and StocksToTrade community, that volatility is the opportunity. As Tim Bohen, lead trainer with StocksToTrade says, “I focus on momentum that’s visible right now. Speculation on future moves is outside my playbook.” That mindset keeps the emphasis on trading the current price action instead of predicting where AVAV will be months or years from now.

The NASA Mars helicopter win, the supportive U.S. tariff backdrop, and upcoming conference appearances add more catalysts to the AeroVironment story. But, as always, it comes down to price action and discipline. As Tim Sykes likes to remind traders, “The market doesn’t care about your opinion, only your preparation and risk management.” For AVAV, the story is strong; the real edge comes from how you trade it.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!